Wnt-15 CRISPR/Cas9 KO Plasmid (h): sc-406368
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- Wnt-15 CRISPR/Cas9 Knockout (KO) Plasmid (h) is a pool of plasmids, each encoding Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed for maximum knockout efficiency using sequences derived from the GeCKO v2 library
- gRNA sequences direct Cas9 to induce site-specific double-strand breaks (DSBs) in the Wnt-15 genomic locus, resulting in gene knockout through non-homologous end joining (NHEJ)
- The puromycin resistance and RFP genes are flanked by LoxP sites, enabling removal of selection markers via Cre recombinase (Cre Vector: sc-418923) after establishing stable knockout cell lines
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Wnt-15 CRISPR/Cas9 KO Plasmid (h) | sc-406368 | 20 µg | $397.00 |
Overview
WNT9B encodes the secreted glycoprotein Wnt-15, a ligand that activates Wnt signaling to regulate cell fate specification, proliferation, polarity, and tissue patterning during development. Through interactions with Frizzled receptors and co-receptors, Wnt-15 can influence β-catenin–dependent transcriptional programs as well as non-canonical pathways controlling cytoskeletal dynamics and directional migration. WNT9B activity is implicated in morphogen gradients that shape organogenesis, with dysregulation of Wnt signaling broadly associated with congenital anomalies and oncogenic processes. In human cell models, WNT9B provides a tractable entry point to dissect pathway cross-talk with growth factor signaling and transcriptional networks governing differentiation.
Wnt-15 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the WNT9B gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the WNT9B together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the WNT9B open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Wnt-15 protein expression.
This CRISPR knockout system enables efficient generation of WNT9B-deficient cell models for investigation of Wnt-15 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
Key Features
- sgRNAs targeting WNT9B exon(s) critical for Wnt-15 function
- Co-expression of SpCas9 and sgRNA from a single plasmid for simplified delivery
- GFP reporter for identification of transfected cells
- Pool of plasmids targeting multiple WNT9B genomic sites to improve knockout efficiency
- Compatible with delivery by transfection
Design Variants
CRISPRs +/- HDRs
- gRNAs encoded by Wnt-15 CRISPR/Cas9 KO Plasmid (h) and Wnt-15 CRISPR/Cas9 KO Plasmid (h2) target distinct sites within the WNT9B locus. One or both targeting designs may be available. See Related Products for availability.
- HDR donor constructs encoded by Wnt-15 HDR Plasmid (h) and Wnt-15 HDR Plasmid (h2) contain a puromycin resistance cassette and an RFP reporter flanked by WNT9B homology arms to support homology-directed repair at defined WNT9B target sites corresponding to the CRISPR/Cas9 KO designs. HDR donor availability may vary. See Related Products for availability.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.